Ginkgo Bioworks Holdings Stock Operating Margin
DNA Stock | USD 0.85 0.02 2.78% |
Ginkgo Bioworks Holdings fundamentals help investors to digest information that contributes to Ginkgo Bioworks' financial success or failures. It also enables traders to predict the movement of Ginkgo Stock. The fundamental analysis module provides a way to measure Ginkgo Bioworks' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ginkgo Bioworks stock.
Last Reported | Projected for Next Year | ||
Operating Profit Margin | (2.67) | (2.81) |
Ginkgo | Operating Margin |
Ginkgo Bioworks Holdings Company Operating Margin Analysis
Ginkgo Bioworks' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Ginkgo Bioworks Operating Margin | (5.16) % |
Most of Ginkgo Bioworks' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ginkgo Bioworks Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Ginkgo Operating Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Ginkgo Bioworks is extremely important. It helps to project a fair market value of Ginkgo Stock properly, considering its historical fundamentals such as Operating Margin. Since Ginkgo Bioworks' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ginkgo Bioworks' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ginkgo Bioworks' interrelated accounts and indicators.
Click cells to compare fundamentals
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition |
Ginkgo Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Ginkgo Bioworks Holdings has an Operating Margin of -5.1553%. This is 85.3% lower than that of the Biotechnology sector and 95.4% lower than that of the Health Care industry. The operating margin for all United States stocks is 6.44% lower than that of the firm.
Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
All Next | Launch Module |
Ginkgo Fundamentals
Return On Equity | -0.63 | ||||
Return On Asset | -0.22 | ||||
Operating Margin | (5.16) % | ||||
Current Valuation | 984.4 M | ||||
Shares Outstanding | 1.65 B | ||||
Shares Owned By Insiders | 6.70 % | ||||
Shares Owned By Institutions | 83.30 % | ||||
Number Of Shares Shorted | 270.83 M | ||||
Price To Earning | 25.51 X | ||||
Price To Book | 1.98 X | ||||
Price To Sales | 8.65 X | ||||
Revenue | 251.46 M | ||||
Gross Profit | 273.49 M | ||||
EBITDA | (600.68 M) | ||||
Net Income | (892.87 M) | ||||
Cash And Equivalents | 1.32 B | ||||
Cash Per Share | 0.84 X | ||||
Total Debt | 241.77 M | ||||
Debt To Equity | 0.03 % | ||||
Current Ratio | 11.84 X | ||||
Book Value Per Share | 0.55 X | ||||
Cash Flow From Operations | (295.5 M) | ||||
Short Ratio | 11.02 X | ||||
Earnings Per Share | (0.46) X | ||||
Target Price | 1.92 | ||||
Number Of Employees | 1.22 K | ||||
Beta | 1.36 | ||||
Market Capitalization | 1.87 B | ||||
Total Asset | 1.67 B | ||||
Retained Earnings | (5.29 B) | ||||
Working Capital | 837.89 M | ||||
Current Asset | 10.07 B | ||||
Current Liabilities | 3.1 B | ||||
Net Asset | 1.67 B |
About Ginkgo Bioworks Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ginkgo Bioworks Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ginkgo Bioworks using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ginkgo Bioworks Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Ginkgo Bioworks Investors Sentiment
The influence of Ginkgo Bioworks' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Ginkgo. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Ginkgo Bioworks' public news can be used to forecast risks associated with an investment in Ginkgo. The trend in average sentiment can be used to explain how an investor holding Ginkgo can time the market purely based on public headlines and social activities around Ginkgo Bioworks Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ginkgo Bioworks' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ginkgo Bioworks' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Ginkgo Bioworks' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Ginkgo Bioworks.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ginkgo Bioworks in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ginkgo Bioworks' short interest history, or implied volatility extrapolated from Ginkgo Bioworks options trading.
Pair Trading with Ginkgo Bioworks
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ginkgo Bioworks position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ginkgo Bioworks will appreciate offsetting losses from the drop in the long position's value.Moving against Ginkgo Stock
0.63 | ELYM | Eliem Therapeutics | PairCorr |
0.62 | ACB | Aurora Cannabis Trending | PairCorr |
0.61 | CGC | Canopy Growth Corp Trending | PairCorr |
0.58 | XFOR | X4 Pharmaceuticals Financial Report 2nd of May 2024 | PairCorr |
0.56 | NRSNW | NeuroSense Therapeutics | PairCorr |
The ability to find closely correlated positions to Ginkgo Bioworks could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ginkgo Bioworks when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ginkgo Bioworks - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ginkgo Bioworks Holdings to buy it.
The correlation of Ginkgo Bioworks is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ginkgo Bioworks moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ginkgo Bioworks Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ginkgo Bioworks can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Ginkgo Bioworks Piotroski F Score and Ginkgo Bioworks Altman Z Score analysis. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Ginkgo Stock analysis
When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Stocks Directory Find actively traded stocks across global markets | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Ginkgo Bioworks' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. If investors know Ginkgo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ginkgo Bioworks listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Revenue Per Share 0.129 | Quarterly Revenue Growth (0.65) | Return On Assets (0.22) | Return On Equity (0.63) |
The market value of Ginkgo Bioworks Holdings is measured differently than its book value, which is the value of Ginkgo that is recorded on the company's balance sheet. Investors also form their own opinion of Ginkgo Bioworks' value that differs from its market value or its book value, called intrinsic value, which is Ginkgo Bioworks' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ginkgo Bioworks' market value can be influenced by many factors that don't directly affect Ginkgo Bioworks' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ginkgo Bioworks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ginkgo Bioworks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.